TP53 and pulmonary arterial hypertension: Disturbed p53 function was noted in pulmonary artery endothelial cells in clinical PAH, and an experimental murine hypoxia-induced PH model also revealed that the genetic depletion of p53 resulted in more severe lung manifestations [42,64].